Down Syndrome Today Magazine

21 Beautiful Faces of Down Syndrome From Around the World | Special Needs Now To celebrate World Down Syndrome Day on March 21, here are 21 photos and descriptions of kids and adults that show the tremendous diversity among people with Down syndrome.

13-year-old singer Madison Tevlin beats the odds and gets Ashton Kutcher's attention Madison Tevlin’s family always knew she had a special spark to share. Now, thanks to her love of singing and a YouTube video gone viral, the world knows it too.

White House ceremony held for Beck and the ABLE Act The late Steve Beck Jr. was a humble man who always followed a game plan. So it was no surprise the Waynesboro native, the driving force behind the

Delaware family celebrates new law for disabled Families can now open savings accounts without risking federal aid

It's time to end segregation of special education students, professors say | The University of... It's time to end segregation of special education students, professors say Tue, 02/10/2015 LAWRENCE — The time has finally come to end the separation of special education and general education students, researchers at the University of Kansas argue in a new publication. Not only does research show t…

Meet the First Model With Down Syndrome to Walk at NYFW This is Jamie Brewer—an actress (known for her work in American Horror Story), model, and now, ru...

How To Deliver A Diagnosis Of Down Syndrome: An Open Letter To OB/GYNs As an Obstetrician it's important for you to deliver a Down syndrome diagnosis with accurate information that honors the child and gives the parents hope.

Progress for persons born with Down syndrome!

The results are now in: the Phase 2 clinical drug trial, sponsored by Transition Therapeutics, was a success! As many of you know, our Down Syndrome Program at Massachusetts General Hospital was one of 3 sites in the country selected to participate in this landmark study. We are thankful to the 6 adults with Down syndrome, and their caregivers, who participated at our clinic.

• What is the study drug supposed to do? The study drug—called ELND005—is believed to have two potential benefits for people with Down syndrome: (1) prevent the accumulation of plaques that might contribute to Alzheimer’s disease, and (2) improve working memory and cognitive functioning by regulating myo-inositol levels in the brain.

Clinical Drug Trial for People with Down Syndrome Successful The results are now in: the Phase 2 clinical drug trial, sponsored by Transition Therapeutics, was a success! As many of you know, our Down Syndrome Program ...